Table 1 Participant characteristics given as mean (SD) or frequency (%)
Age, years | 55.7 (3.6) | Â | Â |
BMI, kg/m2 | 25.6 (4.3) | Â | Â |
| Â | Â | Among women not using medication | |
Sex hormone concentration | Â | 1.quartile (low) Cut-off (mean) | 4.quartile (high) Cut-off (mean) |
   Estradiol nmol/L | 0.10 (0.09) | <0.05] (0.05) | >0.08 (0.14) |
   Progesterone nmol/L | 0.99 (0.67) | <0.55] (0.44) | >1.21 (1.79) |
   Testosterone nmol/L | 1.16 (0.74) | <0.66] (0.50) | >1.54 (2.14) |
   FSH IU/L | 70.2 (28.0) | <56.4] (44.5) | >91.2 (106.4) |
   SHBG nmol/L | 47.6 (21.8) | <32.0] (24.2) | >61.0 (75.1) |
Medication use | 182 (64%) | Â | Â |
   HT | 52 (18%) |  |  |
E2 and E2/P systemic | 32 (62%) | Â | Â |
E2 systemic alone | 9 (17%) | Â | Â |
Tibolone | 10 (19%) | Â | Â |
Vaginal treatment | 9 (17%) | Â | Â |
   Thyroxine | 20 (7%) |  |  |
   Other medication | 159 (56%) |  |  |
   No medication | 98 (34%) |  |  |
Number of medications used (n = 182) | Â | Â | Â |
   1 medication | 97 (53%) |  |  |
   2 medications | 62 (34%) |  |  |
   >2 medications | 23 (13%) |  |  |
Current smoker | Â | Â | Â |
   Yes | 75 (26%) |  |  |
   No | 209 (73%) |  |  |